Randomized phase II trial comparing tumor bed alone with tumor bed and elective nodal postoperative radiotherapy in patients with locoregionally advanced thoracic esophageal squamous cell carcinoma

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Postoperative Radiotherapy ◽

Tumor Bed ◽

Randomized Phase II Trial of Capecitabine Plus Cisplatin Versus Paclitaxel as First Line Treatment for Metastatic Esophageal Squamous Cell Carcinoma

Annals of Oncology ◽

10.1093/annonc/mdt203.59 ◽

2013 ◽

Vol 24 ◽

pp. iv53

Author(s):

Su Jin Lee ◽

Silvia Park ◽

Wonjin Chang ◽

Jung Yong Hong ◽

Moon Ki Choi ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Line Treatment ◽

First Line ◽

Randomized Phase Ii ◽

First Line Treatment

A randomized phase II study of leucovorin, 5-fluorouracil with or without oxaliplatin (LV5FU2 vs. FOLFOX) for curatively-resected, node-positive esophageal squamous cell carcinoma

Annals of Oncology ◽

10.1093/annonc/mdw371.35 ◽

2016 ◽

Vol 27 ◽

pp. vi218

Author(s):

S.H. Lim ◽

Y.-L. Choi ◽

S.-H. Jung ◽

M.-J.A. Ahn ◽

K. Park ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Node Positive ◽

Randomized Phase Ii ◽

Resected Node

Nal-iri/lv5-fu versus paclitaxel as second-line therapy in patients with metastatic esophageal squamous cell carcinoma (OESIRI-PRODIGE 62): A FFCD multicenter, randomized, phase II study

Annals of Oncology ◽

10.1093/annonc/mdz247.168 ◽

2019 ◽

Vol 30 ◽

pp. v324

Author(s):

V. Randrian ◽

A. Adenis ◽

J. Desrame ◽

E. Barbier ◽

F. Di Fiore ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Second Line ◽

Second Line Therapy ◽

Line Therapy ◽

Randomized phase II trial of weekly paclitaxel, carboplatin, cetuximab (PCC) versus cetuximab, docetaxel, cisplatin, and fluorouracil (C-TPF) in previously untreated patients with locally advanced head and neck squamous cell carcinoma.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.tps6102 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. TPS6102-TPS6102 ◽

Cited By ~ 1

Author(s):

Erminia Massarelli ◽

Robert I. Haddad ◽

J. Jack Lee ◽

Adam S. Garden ◽

George R. Blumenschein ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Locally Advanced ◽

Neck Squamous Cell Carcinoma ◽

Advanced Head ◽

Randomized phase II study of recombinant human endostatin combined with definitive chemoradiotherapy in locally advanced esophageal squamous cell carcinoma.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.4035 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 4035-4035 ◽

Cited By ~ 2

Author(s):

Jiahua Lv ◽

Tao Li ◽

Xiaorong Deng ◽

Fang Li ◽

Yanqiong Song ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Locally Advanced ◽

Definitive Chemoradiotherapy ◽

Recombinant Human Endostatin ◽

Phase II Trial of Intensity-Modulated Radiotherapy Concurrent With Chemotherapy for Postoperative Node-Positive Esophageal Squamous Cell Carcinoma

Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics ◽

10.3727/096504017x14889842609577 ◽

2017 ◽

Vol 25 (8) ◽

pp. 1357-1362 ◽

Cited By ~ 1

Author(s):

Hua Tao ◽

Yiqin Zhou ◽

Chengyun Yao ◽

Dayong Gu ◽

Wei Chen ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Intensity Modulated Radiotherapy ◽

Intensity Modulated ◽

Node Positive

Early-stage squamous cell carcinoma of the oropharynx: Radiotherapy vs. Trans-Oral Robotic Surgery (ORATOR) – study protocol for a randomized phase II trial

BMC Cancer ◽

10.1186/1471-2407-13-133 ◽

2013 ◽

Vol 13 (1) ◽

Cited By ~ 82

Author(s):

Anthony C Nichols ◽

John Yoo ◽

J Alex Hammond ◽

Kevin Fung ◽

Eric Winquist ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Robotic Surgery ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Study Protocol ◽

Phase Ii Trial ◽

Early Stage ◽

Responders benefit from neoadjuvant radiochemotherapy in esophageal squamous cell carcinoma: results of a prospective phase-II trial

European Journal of Surgical Oncology ◽

10.1016/j.ejso.2004.06.008 ◽

2004 ◽

Vol 30 (9) ◽

pp. 963-971 ◽

Cited By ~ 37

Author(s):

B.L.D.M. Brücher ◽

H.J. Stein ◽

F. Zimmermann ◽

M. Werner ◽

M. Sarbia ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Neoadjuvant Radiochemotherapy ◽

Prospective Phase

A Phase II Trial of Chemoradiotherapy for Stage I Esophageal Squamous Cell Carcinoma: Japan Clinical Oncology Group Study (JCOG9708)

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyp069 ◽

2009 ◽

Vol 39 (10) ◽

pp. 638-643 ◽

Cited By ~ 162

Author(s):

H. Kato ◽

A. Sato ◽

H. Fukuda ◽

Y. Kagami ◽

H. Udagawa ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Clinical Oncology ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Oncology Group Study

Phase II trial of second-line chemotherapy with docetaxel and capecitabine in advanced esophageal squamous cell carcinoma

Medical Oncology ◽

10.1007/s12032-013-0746-x ◽

2013 ◽

Vol 30 (4) ◽

Cited By ~ 6

Author(s):

Xuyuan Li ◽

Wen Lin ◽

Hongbiao Wang ◽

Wenzhao Lin ◽

Suiling Lin ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Second Line ◽

Second Line Chemotherapy ◽

Line Chemotherapy